Cargando…
Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
Professional antigen-presenting cells (APCs), such as dendritic cells (DCs), are central to the initiation and regulation of anti-cancer immunity. However, in the immunosuppressive environment within a tumor APCs may antagonize anti-tumor immunity by inducing regulatory T cells (Tregs) or anergy of...
Autores principales: | Martin, Kea, Schreiner, Jens, Zippelius, Alfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586505/ https://www.ncbi.nlm.nih.gov/pubmed/26483791 http://dx.doi.org/10.3389/fimmu.2015.00501 |
Ejemplares similares
-
Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023) -
Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023) -
Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
por: dos Reis, Filipa D., et al.
Publicado: (2023) -
The Hippo Pathway in Innate Anti-microbial Immunity and Anti-tumor Immunity
por: Zhang, Qian, et al.
Publicado: (2020) -
Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2021)